Bariatric Surgery Devices Market by Device, Procedure, End User

List of Tables

The Bariatric Surgery Devices Market was valued at USD 1.98 billion in 2023, expected to reach USD 2.13 billion in 2024, and is projected to grow at a CAGR of 7.61%, to USD 3.32 billion by 2030.

Bariatric surgery devices are specialized medical tools designed to aid in weight-loss surgeries that alter the digestive system, such as gastric bypass and sleeve gastrectomy. These devices are necessary due to the rising prevalence of obesity, which has serious health implications like diabetes, hypertension, and cardiovascular diseases. Applications of bariatric surgery devices include restrictive procedures to reduce food intake and malabsorptive procedures to decrease calorie absorption. End-users are primarily hospitals, clinics, and specialized bariatric centers, which require reliable and efficient devices to manage patient health effectively. Key growth factors influencing this market include increasing obesity rates, technological advancements in surgical devices, and rising awareness about obesity-related health risks. Opportunities lie in emerging markets such as Asia-Pacific and Latin America, where obesity rates are climbing rapidly. These regions present immense potential due to their large populations and increasing healthcare infrastructure investments. However, limitations and challenges include high costs associated with bariatric surgeries and devices, stringent regulatory requirements, and the potential for postoperative complications. Despite these challenges, the market is ripe for innovation, especially in developing minimally invasive techniques and more effective postoperative care solutions. Advances in robotic surgery and enhanced imaging technologies offer potential areas for research and development. Additionally, creating cost-effective devices can make surgeries accessible to a broader patient base. The market is competitive yet poised for growth, driven by the continuous demand for innovative solutions to combat obesity. Companies should focus on strategic collaborations and partnerships to expand their reach and engage in robust R&D activities to stay ahead in the market. Overall, the bariatric surgery devices market presents significant opportunities for companies willing to navigate its complexities and leverage technological advancements for sustainable growth.

KEY MARKET STATISTICS
Base Year [2023]	USD 1.98 billion
Estimated Year [2024]	USD 2.13 billion
Forecast Year [2030]	USD 3.32 billion
CAGR (%)	7.61%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bariatric Surgery Devices Market

The Bariatric Surgery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Rising Availability and Preference for Minimally Invasive Techniques
- Increasing Obesity and Overweight among Population
- Favorable Government Expenditure for Bariatric Surgery from Developed Economies
Market Restraints
- Lack of Trained Professionals in Developing Regions
Market Opportunities
- Emerging Technological Advancements in Bariatric Surgery Devices
- Increasing Reimbursement Coverage and Sponsored Bariatric Surgeries
Market Challenges
- Strict Regulatory Guidelines and High Cost of the Devices

Porter's Five Forces: A Strategic Tool for Navigating the Bariatric Surgery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bariatric Surgery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bariatric Surgery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bariatric Surgery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bariatric Surgery Devices Market

A detailed market share analysis in the Bariatric Surgery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bariatric Surgery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bariatric Surgery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Bariatric Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include BIOTRONIK SE & Co KG, Integra LifeSciences Corporation, GI Dynamics Inc., Abbott Laboratories, Stryker Corporation, Apollo Endosurgery, Inc., Grena Ltd., Geyi Medical Instrument, Zimmer Biomet Holdings, Inc., Medtronic PLC, Intuitive Surgical Inc., B. Braun SE, Olympus Corporation, ReShape Lifesciences, Inc., Spatz FGIA, Inc., Asensus Surgical, Inc., Standard Bariatrics, Inc., Johnson & Johnson Private Limited, Edwards Lifesciences, AMI GmbH, USGI Medical Inc., Mediflex Surgical Products, Boston Scientific Corporation, Allurion S.a.s., Cousin Biotech, and CONMED Corporation.

Market Segmentation & Coverage

This research report categorizes the Bariatric Surgery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Device, market is studied across Gastric Balloon, Gastric Band, Surgical Stapler, and Sutures.
Based on Procedure, market is studied across Adjustable Gastric Banding, Biliopancreatic Diversion with Duodenal Switch, Gastric Bypass, Mini-Gastric Bypass, Non-Invasive Bariatric Surgery, Revision Bariatric Surgery, and Sleeve Gastrectomy.
Based on End User, market is studied across Ambulatory Surgery Centers, Clinics, and Hospitals.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-437D4595817D

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising Availability and Preference for Minimally Invasive Techniques
  - 5.1.1.2. Increasing Obesity and Overweight among Population
  - 5.1.1.3. Favorable Government Expenditure for Bariatric Surgery from Developed Economies
- 5.1.2. Restraints
  - 5.1.2.1. Lack of Trained Professionals in Developing Regions
- 5.1.3. Opportunities
  - 5.1.3.1. Emerging Technological Advancements in Bariatric Surgery Devices
  - 5.1.3.2. Increasing Reimbursement Coverage and Sponsored Bariatric Surgeries
- 5.1.4. Challenges
  - 5.1.4.1. Strict Regulatory Guidelines and High Cost of the Devices
5.2. Market Segmentation Analysis
- 5.2.1. Device: Growing preference towards gastric balloons in minimally invasive bariatric surgery
- 5.2.2. Procedure: Rising trends towards non-invasive bariatric surgery
- 5.2.3. End User: Rising demand for bariatric surgery devices from hospitals due to the complexity and range of procedures performed
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
5.5. Client Customization

6. Bariatric Surgery Devices Market, by Device

6.1. Introduction
6.2. Gastric Balloon
6.3. Gastric Band
6.4. Surgical Stapler
6.5. Sutures

7. Bariatric Surgery Devices Market, by Procedure

7.1. Introduction
7.2. Adjustable Gastric Banding
7.3. Biliopancreatic Diversion with Duodenal Switch
7.4. Gastric Bypass
7.5. Mini-Gastric Bypass
7.6. Non-Invasive Bariatric Surgery
7.7. Revision Bariatric Surgery
7.8. Sleeve Gastrectomy

8. Bariatric Surgery Devices Market, by End User

8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Clinics
8.4. Hospitals

9. Americas Bariatric Surgery Devices Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Bariatric Surgery Devices Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Bariatric Surgery Devices Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. ReShape Lifesciences Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band 2.0 FLEX
- 12.3.2. Medtronic will Distribute Allurion's Swallowable Weight-Loss Balloon
- 12.3.3. AdventHealth Redmond Launches New Metabolic and Bariatric Surgery Program

Companies Mentioned

1. BIOTRONIK SE & Co KG
2. Integra LifeSciences Corporation
3. GI Dynamics Inc.
4. Abbott Laboratories
5. Stryker Corporation
6. Apollo Endosurgery, Inc.
7. Grena Ltd.
8. Geyi Medical Instrument
9. Zimmer Biomet Holdings, Inc.
10. Medtronic PLC
11. Intuitive Surgical Inc.
12. B. Braun SE
13. Olympus Corporation
14. ReShape Lifesciences, Inc.
15. Spatz FGIA, Inc.
16. Asensus Surgical, Inc.
17. Standard Bariatrics, Inc.
18. Johnson & Johnson Private Limited
19. Edwards Lifesciences
20. AMI GmbH
21. USGI Medical Inc.
22. Mediflex Surgical Products
23. Boston Scientific Corporation
24. Allurion S.a.s.
25. Cousin Biotech
26. CONMED Corporation